The NNF – a philanthropic non-profit organisation that owns a controlling stake in Danish drugmaker Novo Nordisk – has been ...

The Synthetic Human Genome (SynHG) Project, launched on the 25th anniversary of the mapping of the human genome, is being ...

The UK is studying cases of pancreatitis in people taking drugs based on GLP-1 receptor agonists for weight loss or type 2 ...

The European Commission has cleared the high-strength formulation of Eylea (aflibercept) with an extended treatment interval ...

Success in this area means ensuring the right therapy reaches the patient in a form that is stable, effective, and ready for ...

To close the innovation-access gap, there is a desperate need for an infrastructure rooted in trust. That means complementing ...

At Longeveron, Dr. Joshua Hare and his team are working on an Alzheimer’s treatment using human-derived bone marrow ...

Following a pre-Congress press briefing and data presented onsite at ASCO 2025 itself, pharmaphorum spoke with Dr Victoria ...

An alternative to epinephrine autoinjectors that can be delivered by a nasal spray has been launched in Germany, its first ...

The FDA has launched a review of clinical trials that plan to send American citizens' living cells to 'hostile' countries – ...

As the CEO of ProofPilot, Chris Venezia has a track record of success with more than 18 years of strong leadership in product ...

The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this ...